...
首页> 外文期刊>Journal of surgery and medicine. >Effects of treatment with hydroxychloroquine and azithromycin on the index of cardiac electrophysiological balance in patients with COVID-19: A retrospective cohort study
【24h】

Effects of treatment with hydroxychloroquine and azithromycin on the index of cardiac electrophysiological balance in patients with COVID-19: A retrospective cohort study

机译:羟氯喹和二十霉素治疗对Covid-19患者心脏电生理平衡指标的影响:回顾性队列研究

获取原文
           

摘要

Background/Aim: The common cardiac toxicities of hydroxychloroquine (HCQ) and azithromycin (AZ) are not well defined in COVID-19 patients. Index of cardiac electrophysiological balance (iCEB) is used as a novel risk marker for drug-induced arrhythmias. The purpose of this study was to evaluate ventricular repolarization using iCEB and other conventional ECG parameters such as the end of electrocardiographic T wave (Tp-e) interval, Tp-e/QT ratio, and Tp-e/ heart rate-corrected QT (QTc) ratio in COVID-19 patients treated with HCQ and AZ. Methods: This retrospective study enrolled 164 patients diagnosed with COVID-19 pneumonia in the Emergency Department (ED) and then transferred to the ward or the intensive care unit in April 2020. Results: A total of 164 patients with a mean age of 47 (18) years (range: 18-97 years) included 83 (50.6%) females. There were 38 and 126 patients in Groups HTQ and HTQ+AZ, respectively. On the 5th day of hospitalization, all patients’ heart rates were significantly lower (P0.001), while QTc, QT max (V5-V6), QTmin, Tp-e (V5-V6), and iCEB values were significantly higher (P=0.01 and P0.001 for the rest, respectively) compared to the basal values measured in the ED (P0.001). iCEB values of the HTZ+AZ group were significantly higher than those of the HTQ group (P=0.03). iCEBc strongly positively correlated with Tp-e/QT (V5), and strongly negatively correlated with Tp-e (V5). Conclusion: The iCEB values were increased after HTQ and AZ treatment among COVID-19 patients, and strongly correlated with Tp-e and Tp-e/QT. iCEB is a simple, non-invasive method that can be a useful marker to evaluate ventricular repolarization in COVID-19 patients.
机译:背景/目的:在Covid-19患者中,羟基氯喹(HCQ)和二十霉素(AZ)的常见心脏毒性并不明确定义。心脏电生理平衡指数(ICEB)用作药物诱导心律失常的新风险标志物。本研究的目的是使用ICEB和其他常规ECG参数评估心室复极化,例如心电图T波(TP-E)间隔的结束,TP-E / QT比和TP-E /心率校正QT( Covid-19患者的QTC)比率HCQ和AZ治疗。方法:该回顾性研究注册了164名患者在急诊部(ED)中诊断患有Covid-19肺炎的患者,然后于2020年4月转移到病房或重症监护病房。结果:共有164名患者,平均年龄为47岁( 18)年(范围:18-97岁)包括83名(50.6%)的女性。 HTQ和HTQ + AZ分别有38和126名患者。在住院5天,所有患者的心率明显较低(P <0.001),而QTC,QT MAX(V5-V6),QTMIN,TP-E(V5-V6)和ICEB值明显高(与在ED中测量的基础值相比,P = 0.01和P <0.001分别为静止(P <0.001)。 HTZ + AZ组的ICEB值明显高于HTQ组(P = 0.03)。 Icebc与TP-E / QT(V5)强烈呈正相关,与TP-E(V5)强烈呈负相关。结论:在Covid-19患者中HTQ和AZ治疗后,ICEB值增加,与TP-E和TP-E / QT强烈相关。 ICEB是一种简单的非侵入性方法,可以是评估Covid-19患者心室复极化的有用标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号